Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1990-9-7
pubmed:abstractText
Requirements for the induction of human cytolytic T-lymphocyte (CTL) activity were studied in a monocyte-free T-cell activation system that uses immobilized anti-CD3 monoclonal antibodies (mAb) as a stimulus. Alloreactive CTL with specificity for HLA-A and -B locus antigens could be demonstrated within 2 days after the initiation of activation. CTL induction in purified T cells initiated by an optimal concentration of immobilized anti-CD3 mAb was not enhanced by the addition of monocytes or exogeneous cytokines, whereas addition of anti-CD25 mAb largely blocked the response. Upon suboptimal anti-CD3 mAb stimulation, addition of recombinant interleukin (rIL)-2, rIL-1 and rIL-4, but not recombinant interferon-gamma (IFN-gamma) or rIL-6, potentiated the development of CTL activity. Finally it was shown that immobilized anti-CD3 mAb induced significant levels of CTL activity in both purified CD4+ and CD8+ cells. This study indicates that the requirement for cytokines in the differentiation of CTL precursors depends on the strength of the activation signal delivered through the T-cell receptor.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2456372, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2463100, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2502419, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2525425, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2580895, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2649138, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2784461, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2838549, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2935404, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2960543, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2968520, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-2972366, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3082972, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3086885, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3087758, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3097123, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3102594, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3108668, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3110277, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3117878, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3141268, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3158532, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3257241, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3259965, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3260543, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3261753, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3261754, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3278321, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3320204, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3489775, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3493155, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3494950, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3496227, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3500261, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3500262, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3871453, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-3872800, http://linkedlifedata.com/resource/pubmed/commentcorrection/2143171-6161959
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0019-2805
pubmed:author
pubmed:issnType
Print
pubmed:volume
70
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
357-64
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Generation of alloreactive cytolytic T lymphocytes by immobilized anti-CD3 monoclonal antibodies. Analysis of requirements for human cytolytic T-lymphocyte differentiation.
pubmed:affiliation
Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, University of Amsterdam.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't